- Home
- CRMD vs EMO Comparison
CRMD vs EMO Comparison
Compare CRMD & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- EMO
- Stock Information
- Founded
- CRMD 2006
- EMO 2011
- Country
- CRMD United States
- EMO United States
- Employees
- CRMD N/A
- EMO N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- CRMD Health Care
- EMO Finance
- Exchange
- CRMD Nasdaq
- EMO Nasdaq
- Market Cap
- CRMD 626.8M
- EMO 547.7M
- IPO Year
- CRMD 2010
- EMO N/A
- Fundamental
- Price
- CRMD $10.33
- EMO $49.37
- Analyst Decision
- CRMD Strong Buy
- EMO
- Analyst Count
- CRMD 5
- EMO 0
- Target Price
- CRMD $15.20
- EMO N/A
- AVG Volume (30 Days)
- CRMD 1.6M
- EMO 27.1K
- Earning Date
- CRMD 10-30-2024
- EMO 01-01-0001
- Dividend Yield
- CRMD N/A
- EMO 6.70%
- EPS Growth
- CRMD N/A
- EMO N/A
- EPS
- CRMD N/A
- EMO N/A
- Revenue
- CRMD $12,262,234.00
- EMO N/A
- Revenue This Year
- CRMD N/A
- EMO N/A
- Revenue Next Year
- CRMD $277.75
- EMO N/A
- P/E Ratio
- CRMD N/A
- EMO N/A
- Revenue Growth
- CRMD 41184.20
- EMO N/A
- 52 Week Low
- CRMD $2.89
- EMO $26.42
- 52 Week High
- CRMD $13.85
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- CRMD 47.20
- EMO 82.48
- Support Level
- CRMD $10.16
- EMO $48.02
- Resistance Level
- CRMD $11.41
- EMO $47.40
- Average True Range (ATR)
- CRMD 0.73
- EMO 0.86
- MACD
- CRMD -0.18
- EMO 0.31
- Stochastic Oscillator
- CRMD 31.00
- EMO 99.83
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.